Abbott India, a company in the Pharmaceuticals industry, reported revenue of ₹1,951 crore and net profit of ₹453 crore for the September 2026 quarter.
Abbott India (NSE: ABBOTINDIA) closed at ₹26,525.00 on 20 Nov 2026, down 10.3% over the past year. Its market capitalisation is ₹56,366 crore and it trades at 34.1 times earnings.
Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.